In India, 320 patients with visceral leishmaniasis (209 in the state of Bihar and 11 in the neighboring state of Uttar Pradesh) received identical pentavalent antimony (Sb) treatment. Sb induced long-term cure in 35% (95% confidence interval [CI], 28%-42%) of those in Bihar versus 86% (95% CI, 79%-93%) of those in Uttar Pradesh. In Bihar, the center of the Indian epidemic, traditional Sb treatment should be abandoned.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1086/318121 | DOI Listing |
Publication Analysis
Top Keywords
pentavalent antimony
8
visceral leishmaniasis
8
center indian
8
indian epidemic
8
uttar pradesh
8
failure pentavalent
4
antimony visceral
4
leishmaniasis india
4
india report
4
report center
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!